Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
1.
J Neonatal Perinatal Med ; 7(3): 247-51, 2014 Jan 01.
Article in English | MEDLINE | ID: mdl-25322992

ABSTRACT

Persistent pulmonary hypertension of the newborn (PPHN) results from disruption of the normal fetal-neonatal circulatory transition and may be associated with meconium aspiration, group B streptococcal sepsis, pneumonia, respiratory distress syndrome, congenital diaphragmatic hernia and pulmonary hypoplasia. Seventeen percent of cases are considered idiopathic since there is no identifiable cause. Although it is recognized that acidosis and hypoxia from any cause in neonates may produce pulmonary vasoconstriction and maintain pulmonary hypertension, PPHN has not been reported in inborn errors of metabolism (IEM) associated with metabolic acidosis like methyl malonic acidemia (MMA). We report the first case in the literature of MMA presenting concomitantly with PPHN. Undiagnosed IEMs, like MMA, could represent a subset of idiopathic cases of PPHN. Infants and neonates have a limited repertoire with which to respond to an overwhelming illness. Because metabolic diseases are rare, they are considered only after excluding more common causes of neonatal distress. PPHN is therefore more likely to be attributed to meconium aspiration, sepsis, pneumonia or respiratory distress syndrome than to an IEM. The advent of expanded newborn screening has made pre-symptomatic diagnosis of several IEMs including MMA possible. However, not all IEMs are identified, and in some instances, an infant who has an IEM may become ill before the results of the newborn screen become available. Early diagnosis of IEM is crucial to prevent catastrophic consequences and the awareness of an association with PPHN would lead to an aggressive search of an underlying IEM and its management.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Persistent Fetal Circulation Syndrome/etiology , Amino Acid Metabolism, Inborn Errors/complications , Female , Humans , Infant, Newborn , Persistent Fetal Circulation Syndrome/diagnosis
2.
Am J Med Genet A ; 137A(3): 328-31, 2005 Sep 01.
Article in English | MEDLINE | ID: mdl-16096998

ABSTRACT

We report a 5(1/2)-year-old girl with a maternal family history of Huntington disease (HD), who presented clinically with unbalanced gait, impaired speech, and increasing difficulty with fine motor control. Onset of symptoms began at the age of 3(1/2) years. The suspected diagnosis of juvenile HD, based upon her family history, was confirmed by DNA analysis. At age 7, the patient died secondary to complications of her underlying disorder. Juvenile-onset Huntington disease is uncommon, predominantly transmitted by fathers and is always associated with very large expansions of the CAG repeat. Interestingly, this patient inherited a large CAG size expansion from her mother, who herself had symptoms of HD at the age of 18. Molecular analysis revealed that the mother had 70 CAG repeats whereas our patient had approximately 130 CAG repeats. This is the largest reported CAG expansion from a maternal transmission that has been confirmed molecularly and it demonstrates that very large expansions can also occur through the maternal lineage.


Subject(s)
Huntington Disease/genetics , Nerve Tissue Proteins/genetics , Nuclear Proteins/genetics , Trinucleotide Repeat Expansion/genetics , Alleles , Blotting, Southern , Child , Female , Humans , Huntingtin Protein , Huntington Disease/pathology , Male , Mothers , Pedigree , Trinucleotide Repeats/genetics
3.
Ann Genet ; 44(3): 129-34, 2001.
Article in English | MEDLINE | ID: mdl-11694224

ABSTRACT

We describe two patients (first cousins, once removed) with an unusual head shape, high arched palate, flat nasal bridge, abnormal ears, hand and feet abnormalities and other anomalies. The patients were ascertained independently and it was initially unknown that they were related to each other. Cytogenetic and fluorescent in situ hybridization (FISH) analysis identified a der(2)t(2;10)(q37.3;q24.1) unbalanced translocation resulting in loss of 2q37.3-qter and duplication 10q24.1-qter. The clinical features of these two patients are compared with previously described cases of 2q deletion and 10q duplication. These patients also emphasize the difficulty in some families of understanding and sharing genetic information and in the difficulties in obtaining an accurate pedigree in a genetics clinic.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 10 , Chromosomes, Human, Pair 2 , Gene Duplication , Adolescent , Chromosome Banding , Face/abnormalities , Facies , Family Health , Female , Foot Deformities, Congenital/genetics , Hand Deformities, Congenital/genetics , Humans , In Situ Hybridization, Fluorescence , Infant , Karyotyping , Male , Pedigree , Syndrome , Translocation, Genetic
4.
Mol Genet Metab ; 72(3): 248-53, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11243731

ABSTRACT

A 55-bp deletion in exon 9 of the glucocerebrosidase gene was identified in a 28-year-old male affected with Gaucher disease. The diagnosis was established during an evaluation for mild pancytopenia and was confirmed by bone marrow histology and biochemical studies. The patient is of German ancestry. Initial DNA testing indicated homozygosity for the N370S mutation. However, subsequent testing of the patient's parents suggested that the patient and his mother carried a null allele by our assay for N370S. Further molecular studies identified a 55-bp deletion in exon 9 of the glucocerebrosidase gene (g.6767_6822del55). This deletion has been previously reported in a patient with severe Gaucher disease (1), and is present in the glucocerebrosidase pseudogene. In the previously reported case, initial DNA testing also suggested the genotype N370S/N370S, but further mutation studies were undertaken because clinical severity was greater than expected for that genotype. In contrast, our patient has an unusually mild clinical course. Thus, clinical severity cannot be reliably used to determine when to test for the presence of the 55-bp deletion. While the 55-bp deletion is not reported to be common, its actual frequency may be underestimated since it eludes detection by many standard clinical assays for Gaucher disease. This report points out the need to consider this deletion mutation which may cause erroneous interpretation of results in existing assays for the common mutations N370S and L444P. Furthermore, the importance of recommending parental analysis for individuals who test homozygous for autosomal mutations is highlighted.


Subject(s)
Gaucher Disease/genetics , Glucosylceramidase/genetics , Sequence Deletion , Adult , DNA Mutational Analysis , Gaucher Disease/diagnosis , Humans , Male , Phenotype , Sequence Analysis, DNA , Sequence Deletion/genetics
5.
Am J Med Genet ; 94(2): 120-4, 2000 Sep 11.
Article in English | MEDLINE | ID: mdl-10982968

ABSTRACT

Cationic trypsinogen and cystic fibrosis mutations have been identified in pancreatitis patients, although no study has looked for mutations in both genes in the same patient. Pancreatitis can be induced by alcohol, although not all alcoholics develop pancreatitis. We hypothesize that this phenomenon is due to a genetic predisposition in persons with alcohol-related pancreatitis. We performed sequence analysis of the cationic trypsinogen-coding region in 46 alcohol-related pancreatitis patients and 16 patients with pancreatitis due to causes other than alcohol. We also screened for 40 cystic fibrosis mutations including the 5T allele. No cationic trypsinogen mutations were identified. Cystic fibrosis mutation screening identified the DeltaF508 mutation in two Caucasian alcoholic patients (P<0.025). The cystic fibrosis mutation carrier frequency in African-American alcoholic patients was 3%, which was not significantly increased compared with the normal carrier frequency. The frequency of the 5T allele was not significantly increased compared with the normal population carrier frequency in either racial group. These results may suggest a role for the cystic fibrosis gene in alcohol-related pancreatitis but indicate that cationic trypsinogen mutations are not a common predisposing risk factor for alcohol-related pancreatitis. A multicenter study is necessary to attain sufficient numbers to come to a conclusion.


Subject(s)
Alcohol-Related Disorders/genetics , Cystic Fibrosis/genetics , Pancreatitis/genetics , Trypsin , Trypsinogen/genetics , Adult , Aged , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , DNA Mutational Analysis , Female , Genetic Counseling , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Risk Factors
6.
Surgery ; 128(1): 93-8, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10876191

ABSTRACT

BACKGROUND: Multiple endocrine neoplasia type 2 (MEN 2) and familial medullary thyroid carcinoma (FMTC) are autosomal dominantly inherited cancer syndromes that predispose to C-cell hyperplasia and MTC. MEN 2A and FMTC are caused by mutations in the RET proto-oncogene. METHODS: We used a multiplex polymerase chain reaction-based assay to screen exons 10, 11, 13, and 14 of RET for mutations in 2 families with FMTC. We correlated mutation status with calcitonin and pathologic studies to determine genotype-phenotype correlations. RESULTS: We identified a mutation in codon 804 in exon 14 (GTG-->ATG; V804M) in both families. An 86-year-old person who was a gene carrier and other individuals over age 70 who were suspected by pedigree analysis to be gene carriers had no overt clinical evidence of MTC. Four of 21 patients who underwent a thyroidectomy also had papillary thyroid cancer. One individual in each family had metastatic MTC at age 30 and 32 years, and all 26 people having thyroidectomies had either MTC or C-cell hyperplasia, leading us to continue to recommend prophylactic thyroidectomy for all identified patients who were gene carriers. CONCLUSIONS: Because of active MTC in younger members of these families, including metastases, we have continued to advocate thyroid surgery in mutation-positive individuals. While DNA diagnosis of gene carriers and subsequent genetic counseling was relatively straightforward, the acceptance of surgical recommendations was more difficult for some individuals. These families demonstrate that the search for RET mutations should include exons 13, 14, 15, and 16 in patients whose studies in exons 10 and 11 are negative.


Subject(s)
Carcinoma, Medullary/genetics , Drosophila Proteins , Family Health , Point Mutation , Proto-Oncogene Proteins/genetics , Receptor Protein-Tyrosine Kinases/genetics , Thyroid Neoplasms/genetics , Adult , Age of Onset , Aged , Aged, 80 and over , Carcinoma, Medullary/surgery , Exons , Female , Humans , Male , Middle Aged , Pedigree , Phenotype , Proto-Oncogene Mas , Proto-Oncogene Proteins c-ret , Thyroid Neoplasms/surgery , Thyroidectomy
7.
Am J Hum Genet ; 66(2): 480-93, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10677308

ABSTRACT

Previous studies have shown that specific short-tandem-repeat (STR) and single-nucleotide-polymorphism (SNP)-based haplotypes within and among unaffected and fragile X white populations are found to be associated with specific CGG-repeat patterns. It has been hypothesized that these associations result from different mutational mechanisms, possibly influenced by the CGG structure and/or cis-acting factors. Alternatively, haplotype associations may result from the long mutational history of increasing instability. To understand the basis of the mutational process, we examined the CGG-repeat size, three flanking STR markers (DXS548-FRAXAC1-FRAXAC2), and one SNP (ATL1) spanning 150 kb around the CGG repeat in unaffected (n=637) and fragile X (n=63) African American populations and compared them with unaffected (n=721) and fragile X (n=102) white populations. Several important differences were found between the two ethnic groups. First, in contrast to that seen in the white population, no associations were observed among the African American intermediate or "predisposed" alleles (41-60 repeats). Second, two previously undescribed haplotypes accounted for the majority of the African American fragile X population. Third, a putative "protective" haplotype was not found among African Americans, whereas it was found among whites. Fourth, in contrast to that seen in whites, the SNP ATL1 was in linkage equilibrium among African Americans, and it did not add new information to the STR haplotypes. These data indicate that the STR- and SNP-based haplotype associations identified in whites probably reflect the mutational history of the expansion, rather than a mutational mechanism or pathway.


Subject(s)
Black People/genetics , Fragile X Syndrome/genetics , Genetic Testing , Haplotypes/genetics , Polymorphism, Single Nucleotide/genetics , Tandem Repeat Sequences/genetics , Black or African American , Alleles , Child , Gene Frequency/genetics , Genetic Linkage/genetics , Genetic Markers/genetics , Heterozygote , Humans , Male , Mutagenesis , Trinucleotide Repeat Expansion/genetics , United States , White People/genetics
8.
Am J Med Genet ; 95(4): 361-5, 2000 Dec 11.
Article in English | MEDLINE | ID: mdl-11186891

ABSTRACT

More than 900 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been reported to the cystic fibrosis (CF) consortium. A missense mutation, S1235R, was originally reported in a CF patient with a second mutation (G628R) on the same chromosome. The clinical significance of S1235R was not clear. S1235R is not among the commonly reported mutations, and it is not routinely screened for in most laboratories. However, we have detected the S1235R allele at a frequency that is significantly higher than that of many other CF mutations. Among more than 3,000 patients tested for either a possible diagnosis of CF or to determine CF carrier status, we identified 51 patients heterozygous for S1235R. No patients were homozygous for S1235R. Five patients were compound heterozygotes for a second CFTR mutation: two cases (one family) were N1303K/S1235R and three unrelated cases were deltaF508/S1235R. Our data suggest that S1235R, when combined with a second CF mutation, may be pathogenic, although phenotypic manifestations appear to be variable. The possibility that this represents a rare polymorphism cannot be discounted completely. Genetic counseling is difficult when S1235R is identified, even in the presence of a second known mutation, especially in prenatal cases.


Subject(s)
Amino Acid Substitution/genetics , Arginine/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Mutation, Missense/genetics , Serine/genetics , Adolescent , Adult , Aged , Child , Child, Preschool , Cystic Fibrosis/genetics , Cystic Fibrosis/pathology , Female , Gene Frequency , Humans , Infant , Infant, Newborn , Male , Middle Aged , Pregnancy
10.
Prenat Diagn ; 19(7): 604-9, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10419606

ABSTRACT

Fetal echogenic bowel has been reported as a normal variant in the second trimester, and has also been associated with an adverse fetal outcome, including cystic fibrosis (CF), an autosomal recessive genetic disease. Previous studies have reported that 3.3 to 13.3 per cent of fetuses with echogenic bowel discovered during the second trimester were affected with CF. Between 1994 and 1998 our laboratory tested 159 cases with echogenic bowel detected during a routine ultrasound examination. The ethnic/racial background of cases included Caucasian, African-American, Middle Eastern, Hispanic, Ashkenazi Jewish and Asian. We identified two CF fetuses (1.3 per cent) and eight fetuses with a single identifiable CF mutation (5 per cent) within this diverse population. These data indicated that the risk of CF in a fetus with echogenic bowel in this population was less than the 3.3 to 13.3 per cent prior risk currently used in most Bayesian calculations. Furthermore, the results suggested that specific risks for couples should be calculated using data specific for their ethnic or racial background. Based on our results, we recommend either amniocentesis for fetal CF studies or CF carrier screening of both parents when fetal echogenic bowel is detected as a 1.3 per cent risk of CF is considered high enough to warrant further testing.


Subject(s)
Cystic Fibrosis/diagnostic imaging , Ethnicity , Intestines/diagnostic imaging , Intestines/embryology , Racial Groups , Ultrasonography, Prenatal , Asian , Black People , Cystic Fibrosis/genetics , Female , Hispanic or Latino , Humans , Jews , Mutation , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Pregnancy , Retrospective Studies , Risk Factors , United States , White People
11.
Am J Med Genet ; 85(3): 223-9, 1999 Jul 30.
Article in English | MEDLINE | ID: mdl-10398233

ABSTRACT

Clinical and molecular studies are reported on a family with X-linked mental retardation (XLMR) in which there are eight affected males in three generations. Although the males have somatic manifestations, these are variable and in most cases do not allow clear distinction of affected and unaffected males. Affected males are shorter and have a smaller head circumference. Several also have a sloping forehead (5/8), hearing loss (3/8), cupped ears (2/8), and small testes (4/6). An LOD score of 4.41 with zero recombination was obtained at locus DXS1166 in Xq13.2. This family highlights the difficulty in classifying XLMR conditions as either nonsyndromic or syndromic because of the variable somatic manifestations observed in the affected males.


Subject(s)
Abnormalities, Multiple/genetics , Intellectual Disability/genetics , X Chromosome/genetics , Blotting, Southern , Chromosome Mapping , DNA/genetics , Family Health , Female , Genetic Linkage , Growth Disorders , Humans , Lod Score , Male , Microsatellite Repeats , Pedigree , Skull/abnormalities , Testis/abnormalities
12.
Am J Med Genet ; 84(1): 12-4, 1999 May 07.
Article in English | MEDLINE | ID: mdl-10213039

ABSTRACT

We report on the prenatal diagnosis of a fetus with 46,XY and 46,XX cell lines with a normal male phenotype. Cytogenetic and molecular studies ruled out the possibility of maternal cell contamination and showed that all the X chromosomes present in both fetal cell lines were derived from a single maternal X chromosome. This suggests 46,XY/46,XX mosaicism.


Subject(s)
Mosaicism/genetics , Prenatal Diagnosis , Sex Chromosomes/genetics , Alleles , Apolipoproteins B/genetics , Chimera/genetics , Fetus/metabolism , Humans , Male , Meiosis/genetics , Minisatellite Repeats/genetics , Mitosis/genetics , Phenotype , Polymerase Chain Reaction , Sex Characteristics
13.
Am J Med Genet ; 82(3): 275-81, 1999 Jan 29.
Article in English | MEDLINE | ID: mdl-10215554

ABSTRACT

Uniparental disomy (UPD) is the abnormal inheritance of two copies of a chromosome from the same parent. Possible mechanisms for UPD include trisomy rescue, monosomy rescue, gametic complementation, and somatic recombination. Most of these mechanisms can involve rearranged chromosomes, particularly isochromosomes and Robertsonian translocations. Both maternal and paternal UPD have been reported for most of the acrocentric chromosomes. However, only UPD for chromosomes 14 and 15 show an apparent imprinting effect. Herein, we present two cases of paternal UPD 13 involving isochromosomes. Both cases were referred for UPD studies due to the formation of a de novo rea(13q13q). Case 2 was complicated by the segregation of a familial rob(13q14q) of maternal origin. Both propositi were phenotypically normal at the time of examination. Polymorphic marker analysis in Case 1 showed the distribution of alleles of markers along chromosome 13 to be complete isodisomy, consistent with an isochromosome. This rearrangement could have occurred either meiotically, without recombination, or mitotically. A likely mechanism for UPD in this case is monosomy rescue, through postzygotic formation of the isochromosome. In Case 2 the distribution of proximal alleles indicated an isochromosome, but recombination was evident. Thus, this isochromosome must have formed prior to or during meiosis I. A likely mechanism for UPD in this case is gametic complementation, since the mother carries a rob(13q14q) and is at risk of producing aneuploid gametes. However, trisomy rescue of a trisomy 13 conceptus cannot be completely excluded. Given that both cases were phenotypically normal, these data further support that paternal UPD 13 does not have an adverse phenotypic outcome and, thus, does not show an apparent imprinting effect.


Subject(s)
Chromosome Aberrations , Family Health , Isochromosomes , Alleles , Chromosome Segregation/genetics , Chromosomes, Human, Pair 10/genetics , Chromosomes, Human, Pair 13/genetics , Female , Genetic Markers , Genomic Imprinting , Humans , Infant , Male , Models, Genetic , Monosomy/genetics , Pedigree , Prohibitins , Trisomy/genetics
14.
Am J Med Genet ; 82(4): 336-9, 1999 Feb 12.
Article in English | MEDLINE | ID: mdl-10051168

ABSTRACT

We report on a child with congenital heart disease (atrial septal defect, ventricular septal defect, pulmonic stenosis), submucosal cleft palate, hypernasal speech, learning difficulties, and right fifth finger anomaly manifestations, consistent with velocardiofacial syndrome (VCFS); however, cytogenetic analysis demonstrated a small terminal deletion of the segment 4q34.2 to 4qter. Fluorescent in situ hybridization did not identify a deletion of the critical region associated with VCFS. In previously reported 4q deletions with a breakpoint distal to 4q34.2, no cardiac defects or cleft of palate were reported. Our patient has a deletion of 4q34.2 to 4qter and has palate and cardiac involvement and minor learning difficulties, which implies that genes involved in heart and palate development lie distal to 4q34.2, and that the critical region for more severe mental retardation on 4q may reside proximal to 4q34.2. These results suggest that a distal 4q deletion can lead to a phenotype similar to VCFS and emphasizes the importance of searching for other karyotype abnormalities when a VCFS-like phenotype is present and a 22q deletion is not identified.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Deletion , Chromosomes, Human, Pair 4/genetics , Child , Chromosome Banding , Cleft Palate/genetics , Face/abnormalities , Hand Deformities, Congenital/genetics , Heart Defects, Congenital/genetics , Humans , Learning Disabilities/genetics , Male , Phenotype , Speech Disorders/genetics , Syndrome
15.
Am J Med Genet ; 80(3): 227-31, 1998 Nov 16.
Article in English | MEDLINE | ID: mdl-9843044

ABSTRACT

We report on a 24-year old woman with an Xq duplication and findings suggestive of Prader-Willi syndrome (PWS). Her birth weight was at the 3rd centile and her birth length was less than the 3rd centile. She was hypotonic and had a weak cry as an infant. There were no feeding difficulties, although her mother reports that as an infant, she was "small for her age." Excessive weight gain began between 3 and 4 years. The patient's development was delayed and she received special education. She has a history of hiding food. She has a sleep disturbance disorder and inappropriate social behavior. At the age of 24 years her height was below the 5th centile and weight >>95th centile. She has physical findings typical of PWS, skin picking, and speech articulation defects. Cytogenetic analysis showed a 46,X,dup(X)(q23q25) karyotype. Fluorescent in situ hybridization (FISH) studies using a chromosome X painting probe demonstrated that the rearrangement was intrachromosomal. The X-chromosome fold scoring technique was used to determine the X inactivation pattern and indicated that some cells expressed the abnormal X chromosome. Results of FISH studies using the SNRPN probe localized to 15q11q13 and DNA studies using the PW71B and SNRPN probes were normal. The duplicated X chromosome, random X inactivation pattern, and the negative molecular studies for PWS indicate that the abnormal X chromosome is the basis of this patient's phenotype. This patient emphasizes the importance of obtaining a karyotype even when a syndrome diagnosable by molecular methods is strongly suspected.


Subject(s)
Gene Duplication , Prader-Willi Syndrome/genetics , X Chromosome , Adult , Chromosome Banding , Female , Humans , In Situ Hybridization, Fluorescence
16.
Am J Hematol ; 58(3): 213-7, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9662273

ABSTRACT

Homozygosity for the mutation Cys282Tyr in the HFE gene has recently been identified as a cause of hereditary hemochromatosis, a disorder resulting in the inappropriate absorption of iron. Approximately 10% of Caucasians are heterozygous for this mutation; however, the gene frequency in African Americans is unknown. A study of a control population of African Americans was performed to determine the frequency of the Cys282Tyr and His63Asp alleles in this ethnic group. The carrier frequency for each mutant allele in our African American population was 3.0%. DNA studies of four African-American hemochromatosis patients did not identify any individuals with the Cys282Tyr allele. These findings suggest that if the Cys282Tyr mutation confers susceptibility to hemochromatosis in Caucasians (as suggested by recent studies) there is an alternative mechanism for hemochromatosis in the American black population.


Subject(s)
Black People/genetics , HLA Antigens/genetics , Hemochromatosis/genetics , Histocompatibility Antigens Class I/genetics , Membrane Proteins , Mutation/genetics , Adult , Aged , Alleles , Asian People/genetics , DNA/analysis , Female , Gene Frequency , Hemochromatosis/epidemiology , Hemochromatosis Protein , Heterozygote , Homozygote , Humans , Male , Polymerase Chain Reaction , Prevalence , White People/genetics
19.
Neuromuscul Disord ; 8(1): 30-8, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9565988

ABSTRACT

The sarcoglycan complex is involved in the etiology of four autosomal recessive limb-girdle muscular dystrophies (LGMD2C-F). A missense mutation (T151R) in the beta-sarcoglycan gene on chromosome 4q12 has been shown to cause a mild form of LGMD2E in 11 families from a Southern Indiana Amish community sharing a common haplotype. We now report that two sibs from another Amish family with mild LGMD2E are compound heterozygotes for chromosome 4q12 markers. In order to characterize the genetic defect in this new family, we determined the genomic organization of the beta-sarcoglycan gene. A second missense mutation (R91C) has now been identified in this LGMD2E Amish family. This mutation is also present in the homozygous state in another family of probable Amish ancestry. Finally, analysis of all the components of the dystrophin-glycoprotein complex was performed for the first time on a biopsy from a patient homozygous for the beta-sarcoglycan mutation (T151R). Interestingly, in addition to the loss of the entire sarcoglycan complex, we detected a reduction of alpha-dystroglycan which suggests a role for the sarcoglycan complex in stabilizing alpha-dystroglycan at the sarcolemma.


Subject(s)
Chromosomes, Human, Pair 4 , Cytoskeletal Proteins/genetics , Ethnicity/genetics , Membrane Glycoproteins/genetics , Muscular Dystrophies/genetics , Point Mutation , Adolescent , Adult , Alternative Splicing , Base Sequence , Child , Chromosome Mapping , Dystroglycans , Dystrophin , Exons , Female , Genes, Recessive , Genetic Carrier Screening , Haplotypes , Homozygote , Humans , Hypertrophy , Indiana , Introns , Male , Middle Aged , Muscle, Skeletal/pathology , Muscular Dystrophies/pathology , Muscular Dystrophies/physiopathology , Nuclear Family
SELECTION OF CITATIONS
SEARCH DETAIL
...